A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

NCT00140855 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Study discontinued due to poor accrual.

Conditions

Synovial Sarcoma

Interventions

BIOLOGICAL: ipilimumab

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]